2025-07-24 - Analysis Report
Okay, here's a report analyzing Transmedics Group Inc (TMDX), incorporating all the provided information.

## Transmedics Group Inc (TMDX) Analysis Report

**Company Overview:** Transmedics Group Inc is a medical technology company pioneering a novel approach to organ preservation for transplantation.

### 1. Performance vs. S&P 500 (VOO)

*   **TMDX Cumulative Return:** 224.69%
*   **VOO Cumulative Return:** 68.64%
*   **Absolute Difference:** 156.0
*   **Relative Difference:** 61.1 (This means the current difference is at the 61.1 percentile of its historical range relative to VOO.)

**Analysis:** TMDX has significantly outperformed the S&P 500 (VOO). The relative difference suggests that while TMDX's outperformance is substantial, it's not at the extreme upper end of its historical range compared to the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta | Cap(B) |
|------------|---------|---------|----------|------|--------|
| 2019-2021  | -4.0%   | 63.4%   | -52.0%   | 0.0  | 0.7    |
| 2020-2022  | 140.0%  | 68.3%   | 138.0%   | 0.1  | 2.2    |
| 2021-2023  | 95.0%   | 69.4%   | 77.0%    | 0.2  | 2.8    |
| 2022-2024  | 147.0%  | 82.8%   | 121.0%   | 0.2  | 2.2    |
| 2023-2025  | 106.0%  | 82.8%   | 57.0%    | 0.5  | 3.7    |

**Analysis:**

*   **CAGR:**  Shows impressive growth over the more recent periods (2020-2025).
*   **MDD:**  High Maximum Drawdown values indicate significant volatility.
*   **Alpha:**  Very high Alpha values demonstrate substantial outperformance relative to the market risk.
*   **Beta:**  Low Beta values indicate that the stock's volatility is lower than the market's volatility.
*   **Cap(B):** The company's market capitalization is increasing over time.

### 2. Recent Stock Price Movement

*   **Current Price:** 105.60
*   **Last Market Data:** {'price': 110.38, 'previousClose': 105.6, 'change': 4.53}
*   **5-Day Moving Average:** 108.99
*   **20-Day Moving Average:** 121.78
*   **60-Day Moving Average:** 120.40

**Analysis:**

*   The recent market data shows a significant price increase (change: 4.53), indicating a potential short-term rebound.
*   The current price is below the 5-day, 20-day, and 60-day moving averages, suggesting a downtrend, but the recent price surge might signal a reversal.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 21.39 (Oversold)
*   **PPO:** -2.07 (Negative, indicating a downtrend)
*   **Hybrid Signal:** cash_69%_Sell 0.7% of holdings (4 shares - Caution - MRI:0.35)
*   **Delta_Previous_Relative_Divergence (20-day):** -2.7 (Negative - short-term decline)
*   **Expected Return:** 61.7% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** Indicates a low-risk environment, which may be misleading given the stock's volatility.
*   **RSI:** The oversold RSI suggests the stock may be due for a rebound.
*   **PPO:** Confirms the downtrend suggested by the moving averages.
*   **Hybrid Signal:**  Suggests a cautious approach, recommending a partial sale of holdings.
*   **The price change** reflects a short-term event, indicating a quick upturn.
*   **Expected Return:** The high expected return suggests a positive long-term outlook if the stock is held for a long term.

### 4. Recent News & Significant Events

*   **Volatility:** The stock has shown notable volatility.
*   **Analyst Discussions:** Analysts are discussing recent performance in the context of industry trends and global economic factors.
*   **Business Developments/Regulatory Changes:**  Recent developments may be influencing the stock.
*   **Monitor Company Announcements:** Investors are advised to monitor recent news and company announcements.

**Analysis:** These news snippets indicate heightened market awareness of TMDX, likely due to recent events or performance shifts. Investors should carefully monitor these developments.

### 5. Recent Earnings Analysis

| Date       | EPS  | Expected EPS |
|------------|------|--------------|
| 2025-05-08 | 0.70 | 0.29         |
| 2025-02-27 | 0.19 | 0.22         |
| 2024-10-28 | 0.12 | 0.29         |
| 2024-07-31 | 0.35 | 0.21         |
| 2024-04-30 | 0.35 | 0.03         |

**Analysis:**

*   In the most recent quarter (2025-05-08), Transmedics significantly exceeded EPS expectations.
*   Prior to that, the company either met or missed expectations.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.14B  | 61.47%        |
| 2024-12-31 | $0.12B  | 59.21%        |
| 2024-09-30 | $0.11B  | 55.94%        |
| 2024-06-30 | $0.11B  | 60.59%        |
| 2024-03-31 | $0.10B  | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE    |
|------------|---------|--------|
| 2025-03-31 | $0.27B  | 9.64%  |
| 2024-12-31 | $0.23B  | 3.00%  |
| 2024-09-30 | $0.21B  | 2.01%  |
| 2024-06-30 | $0.19B  | 6.42%  |
| 2024-03-31 | $0.16B  | 7.65%  |

**Analysis:**

*   **Revenue:**  Shows a consistent upward trend over the quarters.
*   **Profit Margin:**  Remains high and relatively stable, indicating strong profitability.
*   **Equity:** Increasing equity indicates financial strength.
*   **ROE:**  Fluctuates but generally indicates positive returns on equity.

### 7. Overall Analysis & Summary

Transmedics Group Inc (TMDX) has demonstrated significant outperformance compared to the S&P 500, driven by strong revenue growth and high-profit margins. Recent earnings have exceeded expectations. However, the stock exhibits considerable volatility, as reflected in its high Maximum Drawdown and recent price fluctuations.

**Key Takeaways:**

*   **High Growth Potential:** The company shows strong growth prospects.
*   **Volatility:** Investors should be prepared for significant price swings.
*   **Strong Financials:** Revenue, profit margins, and equity are trending positively.
*   **Recent Uptick:** The recent price surge and oversold RSI suggest a potential short-term rebound.
*   **Cautious Outlook:** The Hybrid Signal indicates a need for careful monitoring and potential profit-taking strategies.

**Recommendation:**

While TMDX presents a compelling growth opportunity, its volatility and recent downtrend require a cautious approach. Consider a long-term, dollar-cost averaging strategy, closely monitoring news and company announcements. The high expected return makes it attractive for long-term investment if the company maintains its growth trajectory.
